Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα
Open Access
- 19 March 2014
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 75 (5) , 670-683
Abstract
Objective: Bacterial infection contributes to diverse noninfectious diseases and worsens outcome after stroke. Streptococcus pneumoniae, the most common infection in patients at risk of stroke, is a major cause of prolonged hospitalization and death of stroke patients, but how infection impacts clinical outcome is not known.Methods: We induced sustained pulmonary infection by a human S. pneumoniae isolate in naive and comorbid rodents to investigate the effect of infection on vascular and inflammatory responses prior to and after cerebral ischemia.Results: S. pneumoniae infection triggered atherogenesis, led to systemic induction of interleukin (IL) 1, and profoundly exacerbated (50–90%) ischemic brain injury in rats and mice, a response that was more severe in combination with old age and atherosclerosis. Systemic blockade of IL‐1 with IL‐1 receptor antagonist (IL‐1Ra) fully reversed infection‐induced exacerbation of brain injury and functional impairment caused by cerebral ischemia. We show that infection‐induced systemic inflammation mediates its effects via increasing platelet activation and microvascular coagulation in the brain after cerebral ischemia, as confirmed by reduced brain injury in response to blockade of platelet glycoprotein (GP) Ibα. IL‐1 and platelet‐mediated signals converge on microglia, as both IL‐1Ra and GPIbα blockade reversed the production of IL‐1α by microglia in response to cerebral ischemia in infected animals.Interpretation: S. pneumoniae infection augments atherosclerosis and exacerbates ischemic brain injury via IL‐1 and platelet‐mediated systemic inflammation. These mechanisms may contribute to diverse cardio‐ and cerebrovascular pathologies in humans. Ann Neurol 2014;75:670–683Keywords
This publication has 42 references indexed in Scilit:
- Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-upBMC Public Health, 2012
- Rheumatic heart diseaseThe Lancet, 2012
- Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic TargetCerebrovascular Diseases, 2011
- Pneumococcal Vaccination and Risk of Acute Myocardial Infarction and Stroke in MenJAMA, 2010
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Acute ischaemic stroke and infection: recent and emerging conceptsThe Lancet Neurology, 2008
- The Association between Pneumococcal Pneumonia and Acute Cardiac EventsClinical Infectious Diseases, 2007
- Risk of Myocardial Infarction and Stroke after Acute Infection or VaccinationNew England Journal of Medicine, 2004
- Community‐Acquired Pneumonia in the ElderlyClinical Infectious Diseases, 2000
- Community-Acquired PneumoniaClinical Infectious Diseases, 1994